PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco - David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23 in San Francisco, CA - GTCbio.com
David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2011/06/08 - David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23 in San Francisco, CA - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

David S. Goldstein, M.D. Ph.D., Senior Investigator and Chief of Clinical Neurocardiology at NINDS, NIH to give a keynote presentation titled “Willie Sutton’s Getaway Car and the Pathogenesis of Lewy Body Diseases” at GTC’s Advances in Neuropsychiatric Treatment Conference on Sept 22-23, 2011 in San Francisco, CA

Dr. Goldstein has been at NIH since 1978, tenured in 1984 (NHLBI), and founded and still leads the Clinical Neurocardiology Section in intramural NINDS in 1999. His discoveries include cardiac sympathetic denervation in Parkinson disease, stressor-specific activation of the sympathetic noradrenergic and adrenomedullary hormonal systems, sympathoadrenal imbalance preceding neurocardiogenic syncope, autoimmune autonomic ganglionopathy, and decreased vesicular uptake of neuronal catecholamines in Lewy body diseases. His current research focuses on biomarkers and mechanisms of loss of catecholaminergic neurons in Parkinson disease and related disorders.

Dr. Goldstein will present a conceptual framework for answering four key questions about the pathogenesis of Lewy body diseases. (1) Only a very small percent of neurons are catecholaminergic. What renders them susceptible? (2) All genotypic abnormalities identified so far that cause familial PD have no obvious relationship to catecholamines. How do generalized genetic predispositions lead to relatively specific loss of catecholaminergic neurons? (3) The protein alpha-synuclein is expressed in all neurons, and precipitated alpha-synuclein is a prominent component of Lewy bodies. Why does alpha-synuclein tend to precipitate in the cytosol of catecholaminergic neurons? And (4) Why are PD and DLB diseases of the elderly? The analogy of Willie Sutton’s getaway car provides a basis for new ideas about potential diagnostic, treatment, and preventative strategies in Lewy body diseases.

Other topics to be discussed at the conference include Neuroimaging Techniques for Drug Discovery, Neuropsychiatric Therapeutics, Cognition across Neuropsychiatric Disorders, New Treatments Hiding in Glutamate Synapses, The Role of Epigenetics and Genomics, and Lessons & Success in Clinical Trials.

Also presenting at the Advances in Neuropsychiatric Treatment Conference are prestigious organizations including Abbott, Addex Pharma, Amgen, Johnson & Johnson, National Psychosis Service (UK), Neuronetics, NIDA, NIH, Roche, Stanford, UC San Francisco, University of Michigan, UNC School of Medicine, Weill Cornell Med and other leaders in the neuroscience and psychiatry fields. For more information, please visit gtcbio.com/.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


David Goldstein Chief NINDS to Speak At Neuropsychiatry Conference, September 22-23 in San Francisco

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)